Showing 241-250 of 9322 results for "".
Building Dermatology Patient Relationships with AI Chat and Text Messaging
https://practicaldermatology.com/topics/practice-management/building-dermatology-patient-relationships-with-ai-chat-and-text-messaging/23188/Automated communication tools could actually be the secret to a personal touch.How to Get Job Seekers to Apply to Your Job
https://practicaldermatology.com/topics/practice-management/how-to-get-job-seekers-to-apply-to-your-job/23152/Learn the secrets to getting qualified physicians to apply to your job.Protecting Your Most Valuable Asset: Insurance
https://practicaldermatology.com/topics/practice-management/protecting-your-most-valuable-asset-insurance/20817/A refresher on what you need to know about term life, permanent (cash value) life, and disability insurance.Improving Therapeutic Outcomes for Acne Patients Using Topical Medications
https://practicaldermatology.com/topics/practice-management/improving-therapeutic-outcomes-for-acne-patients-using-topical-medications/20403/Four pearls for making today's acne therapies work for your patients.Emerging Business Concept: The Acne Treatment Center
https://practicaldermatology.com/topics/practice-management/emerging-business-concept-the-acne-treatment-center/20700/What if there was a practice devoted solely to the treatment of acne and acne scars?Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/20866/Nine reasons physician-investors underperform without professional investment advice.Multi-Faceted approaches to rosacea Management
https://practicaldermatology.com/topics/general-topics/multi-faceted-approaches-to-rosacea-management/22919/Patients are increasingly using cosmeceuticals—with and without prescription agents— to manage symptoms of rosacea.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muThe Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.